Aspirin and Rash erythematous aggravated - a phase IV clinical study of FDA data

Summary:

Rash erythematous aggravated is reported as a side effect among people who take Aspirin (aspirin), especially for people who are female, 60+ old, have been taking the drug for < 1 month also take Revlimid, and have High blood cholesterol.

The phase IV clinical study analyzes which people have Rash erythematous aggravated when taking Aspirin. It is created by eHealthMe based on reports of 622,087 people who have side effects when taking Aspirin from the FDA, and is updated regularly.

What is Aspirin?

Aspirin has active ingredients of aspirin. It is often used in blood clots. eHealthMe is studying from 632,088 Aspirin users. Check the latest studies of Aspirin.

What is Rash erythematous aggravated?

Rash erythematous aggravated (redness of the skin) is found to be associated with 1,394 drugs and 601 conditions by eHealthMe. Check the latest studies of Rash erythematous aggravated.

On Jul, 11, 2026

622,087 people reported to have side effects when taking Aspirin.
Among them, 1,681 people (0.27%) have Rash erythematous aggravated.

Could Aspirin cause Rash erythematous aggravated?

Among these 1,681 people:

How long have people been on Aspirin when they have Rash erythematous aggravated? *

Click here to view more results

What is the gender of people who have Rash erythematous aggravated when taking Aspirin? *

Click here to view

What is the age of people who have Rash erythematous aggravated when taking Aspirin? *

Click here to view more results

* Approximation only. Some reports may have incomplete information.

Do you take Aspirin and have Rash erythematous aggravated?

- Check whether Rash erythematous aggravated is associated with a drug or a condition
- Predict drug outcomes for up to one year with AI
- Get an AI agent to monitor your drugs continuously

Related studies:

Effectiveness of, long term effects of, and alternative drugs to Aspirin:

Aspirin (632,088 reports)

Rash erythematous aggravated treatments and more:

Rash erythematous aggravated (32 reports)

How severe was Rash erythematous aggravated and when was it recovered:

Rash erythematous aggravated in Aspirin

Expand to all the drugs that have ingredients of aspirin:

Rash erythematous aggravated and drugs with ingredients of aspirin (2,057 reports)

Sub-studies by gender and age:

Female: 0-1 2-9 10-19 20-29 30-39 40-49 50-59 60+

Male: 0-1 2-9 10-19 20-29 30-39 40-49 50-59 60+

Browse all side effects of Aspirin:

a b c d e f g h i j k l m n o p q r s t u v w x y z

Browse all the drugs that are associated with Rash erythematous aggravated:

Rash erythematous aggravated (1,394 drugs)

Browse all the conditions that are associated with Rash erythematous aggravated:

Rash erythematous aggravated (601 conditions)

Related publications that referenced our studies

Alokaily FA, Alghamdi M, Almalki AS, Alhussaini H, "Aspirin induced leukocytoclastic vasculitis, lower gastrointestinal hemorrhage and acute renal failure (mimicking systemic vasculitis)", Saudi medical journal, 2013 Apr .
Alokaily FA, Alghamdi M, Almalki AS, Alhussaini H, "Aspirin induced leukocytoclastic vasculitis, lower gastrointestinal hemorrhage and acute renal failure (mimicking systemic vasculitis)", Saudi medical journal, 2013 Apr .

How the study uses the data?

The study uses data from the FDA. It is based on aspirin (the active ingredients of Aspirin) and Aspirin (the brand name). Other drugs that have the same active ingredients (e.g. generic drugs) are not considered. Dosage of drugs is not considered in the study.

How to use the study?

DO NOT STOP MEDICATIONS without first consulting your doctor. If there are any serious or long term adverse effects discovered in the study, discuss the study with your doctor to ensure that proper medication management will be in place if applicable.

Who is eHealthMe?

With medical big data and proven AI/ML algorithms, eHealthMe provides a platform for everyone to run phase IV clinical trials. We study millions of patients and 5,000 more each day. Results of our real-world drug study have been referenced on 800+ peer-reviewed medical publications, including The Lancet, Mayo Clinic Proceedings, and Nature. Our analysis results are available to researchers, health care professionals, patients (testimonials), and software developers (open API).

WARNING, DISCLAIMER, USE FOR PUBLICATION

WARNING: Please DO NOT STOP MEDICATIONS without first consulting a physician since doing so could be hazardous to your health.

DISCLAIMER: All material available on eHealthMe.com is for informational purposes only, and is not a substitute for medical advice, diagnosis, or treatment provided by a qualified healthcare provider. All information is observation-only. Our phase IV clinical studies alone cannot establish cause-effect relationship. Different individuals may respond to medication in different ways. Every effort has been made to ensure that all information is accurate, up-to-date, and complete, but no guarantee is made to that effect. The use of the eHealthMe site and its content is at your own risk.

If you use this eHealthMe study on publication, please acknowledge it with a citation: study title, URL, accessed date.